Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Community level socioeconomic status association with surgical outcomes and resource utilisation in a regional cohort: a prospective registry analysis.

Mehaffey JH, Hawkins RB, Charles EJ, Turrentine FE, Kaplan B, Fogel S, Harris C, Reines D, Posadas J, Ailawadi G, Hanks JB, Hallowell PT, Jones RS.

BMJ Qual Saf. 2019 Sep 20. pii: bmjqs-2019-009800. doi: 10.1136/bmjqs-2019-009800. [Epub ahead of print]

PMID:
31540969
2.

A fluorescent assay for the genetic dissection of the RNA polymerase II termination machinery.

Reines D.

Methods. 2019 Apr 15;159-160:124-128. doi: 10.1016/j.ymeth.2018.12.011. Epub 2019 Jan 5. Review.

PMID:
30616008
3.

Nab3's localization to a nuclear granule in response to nutrient deprivation is determined by its essential prion-like domain.

Loya TJ, O'Rourke TW, Simke WC, Kelley JB, Reines D.

PLoS One. 2018 Dec 17;13(12):e0209195. doi: 10.1371/journal.pone.0209195. eCollection 2018.

4.

Compositional complexity of rods and rings.

Schiavon CR, Griffin ME, Pirozzi M, Parashuraman R, Zhou W, Jinnah HA, Reines D, Kahn RA.

Mol Biol Cell. 2018 Sep 15;29(19):2303-2316. doi: 10.1091/mbc.E18-05-0274. Epub 2018 Jul 19.

5.

The hnRNP-like Nab3 termination factor can employ heterologous prion-like domains in place of its own essential low complexity domain.

Loya TJ, O'Rourke TW, Reines D.

PLoS One. 2017 Oct 12;12(10):e0186187. doi: 10.1371/journal.pone.0186187. eCollection 2017.

6.

Recent advances in understanding transcription termination by RNA polymerase II.

Loya TJ, Reines D.

F1000Res. 2016 Jun 23;5. pii: F1000 Faculty Rev-1478. doi: 10.12688/f1000research.8455.1. eCollection 2016. Review.

7.

Determinants of Amyloid Formation for the Yeast Termination Factor Nab3.

O'Rourke TW, Reines D.

PLoS One. 2016 Mar 8;11(3):e0150865. doi: 10.1371/journal.pone.0150865. eCollection 2016.

8.

Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II.

Arndt KM, Reines D.

Annu Rev Biochem. 2015;84:381-404. doi: 10.1146/annurev-biochem-060614-034457. Epub 2015 Mar 26. Review.

9.

Amyloid-like assembly of the low complexity domain of yeast Nab3.

O'Rourke TW, Loya TJ, Head PE, Horton JR, Reines D.

Prion. 2015;9(1):34-47. doi: 10.1080/19336896.2014.997618. Epub 2015 Jan 22.

10.

A network of interdependent molecular interactions describes a higher order Nrd1-Nab3 complex involved in yeast transcription termination.

Loya TJ, O'Rourke TW, Degtyareva N, Reines D.

J Biol Chem. 2013 Nov 22;288(47):34158-67. doi: 10.1074/jbc.M113.516765. Epub 2013 Oct 7.

11.

Yeast Nab3 protein contains a self-assembly domain found in human heterogeneous nuclear ribonucleoprotein-C (hnRNP-C) that is necessary for transcription termination.

Loya TJ, O'Rourke TW, Reines D.

J Biol Chem. 2013 Jan 25;288(4):2111-7. doi: 10.1074/jbc.M112.430678. Epub 2012 Nov 28.

12.

Decapping goes nuclear.

Reines D.

Mol Cell. 2012 May 11;46(3):241-2. doi: 10.1016/j.molcel.2012.04.016.

13.

A genetic screen for terminator function in yeast identifies a role for a new functional domain in termination factor Nab3.

Loya TJ, O'Rourke TW, Reines D.

Nucleic Acids Res. 2012 Aug;40(15):7476-91. doi: 10.1093/nar/gks377. Epub 2012 May 7.

14.

A quality committee's evaluation of surgical intervention for Clostridium difficile infection.

Vasaly FW, Reines D.

AORN J. 2009 Aug;90(2):192-200; quiz 201-4.

PMID:
19736671
15.

Properties of an intergenic terminator and start site switch that regulate IMD2 transcription in yeast.

Jenks MH, O'Rourke TW, Reines D.

Mol Cell Biol. 2008 Jun;28(12):3883-93. doi: 10.1128/MCB.00380-08. Epub 2008 Apr 21.

16.

Metabolic regulation of IMD2 transcription and an unusual DNA element that generates short transcripts.

Kopcewicz KA, O'Rourke TW, Reines D.

Mol Cell Biol. 2007 Apr;27(8):2821-9. Epub 2007 Feb 12.

17.

Transcription, translation and fragile X syndrome.

Garber K, Smith KT, Reines D, Warren ST.

Curr Opin Genet Dev. 2006 Jun;16(3):270-5. Epub 2006 May 2. Review.

PMID:
16647847
18.
19.
20.

Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.

McPhillips CC, Hyle JW, Reines D.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12171-6. Epub 2004 Aug 3.

21.

Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo.

Smith KT, Coffee B, Reines D.

Hum Mol Genet. 2004 Aug 1;13(15):1611-21. Epub 2004 Jun 2.

PMID:
15175277
22.
23.

Use of RNA yeast polymerase II mutants in studying transcription elongation.

Reines D.

Methods Enzymol. 2003;371:284-92. No abstract available.

24.
25.

Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Coffee B, Zhang F, Ceman S, Warren ST, Reines D.

Am J Hum Genet. 2002 Oct;71(4):923-32. Epub 2002 Sep 13.

26.

Use of an in vivo reporter assay to test for transcriptional and translational fidelity in yeast.

Shaw RJ, Bonawitz ND, Reines D.

J Biol Chem. 2002 Jul 5;277(27):24420-6. Epub 2002 May 2.

27.

Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II.

Tornaletti S, Maeda LS, Lloyd DR, Reines D, Hanawalt PC.

J Biol Chem. 2001 Nov 30;276(48):45367-71. Epub 2001 Sep 24.

28.

Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.

Shaw RJ, Wilson JL, Smith KT, Reines D.

J Biol Chem. 2001 Aug 31;276(35):32905-16. Epub 2001 Jul 5.

29.
31.

Transcription elongation factor SII.

Wind M, Reines D.

Bioessays. 2000 Apr;22(4):327-36. Review.

33.

Mechanism and regulation of transcriptional elongation by RNA polymerase II.

Reines D, Conaway RC, Conaway JW.

Curr Opin Cell Biol. 1999 Jun;11(3):342-6. Review.

34.

Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.

Coffee B, Zhang F, Warren ST, Reines D.

Nat Genet. 1999 May;22(1):98-101. Erratum in: Nat Genet 1999 Jun;22(2):209.

PMID:
10319871
35.

Mutations in RNA polymerase II and elongation factor SII severely reduce mRNA levels in Saccharomyces cerevisiae.

Lennon JC 3rd, Wind M, Saunders L, Hock MB, Reines D.

Mol Cell Biol. 1998 Oct;18(10):5771-9.

36.
37.

Nucleotide sequence context effect of a cyclobutane pyrimidine dimer upon RNA polymerase II transcription.

Tornaletti S, Donahue BA, Reines D, Hanawalt PC.

J Biol Chem. 1997 Dec 12;272(50):31719-24.

38.

Assays for investigating transcription by RNA polymerase II in vitro.

Reines D, Dvir A, Conaway JW, Conaway RC.

Methods. 1997 Jul;12(3):192-202. Review.

PMID:
9237163
39.

Glutamic acid-371 of the barnase homology domain in RNA polymerase II is not required for SII-activated RNA cleavage.

Powell W, Lennon JC, Elsevier JP, Reines D.

Mol Gen Genet. 1997 Jan 27;253(4):507-11.

PMID:
9037112
40.

Elongation factor SII contacts the 3'-end of RNA in the RNA polymerase II elongation complex.

Powell W, Bartholomew B, Reines D.

J Biol Chem. 1996 Sep 13;271(37):22301-4.

41.

The RNA polymerase II general elongation factors.

Reines D, Conaway JW, Conaway RC.

Trends Biochem Sci. 1996 Sep;21(9):351-5. Review.

42.

Transcription elongation factor SII (TCEA) maps to human chromosome 3p22 --> p21.3.

DiMarco SP, Glover TW, Miller DE, Reines D, Warren ST.

Genomics. 1996 Aug 15;36(1):185-8.

PMID:
8812434
43.

Increased accommodation of nascent RNA in a product site on RNA polymerase II during arrest.

Gu W, Wind M, Reines D.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6935-40.

44.

Effects of aminofluorene and acetylaminofluorene DNA adducts on transcriptional elongation by RNA polymerase II.

Donahue BA, Fuchs RP, Reines D, Hanawalt PC.

J Biol Chem. 1996 May 3;271(18):10588-94.

46.

Purification of RNA polymerase II general transcription factors from rat liver.

Conaway RC, Reines D, Garrett KP, Powell W, Conaway JW.

Methods Enzymol. 1996;273:194-207. Review. No abstract available.

50.

Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template.

Donahue BA, Yin S, Taylor JS, Reines D, Hanawalt PC.

Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8502-6.

Supplemental Content

Loading ...
Support Center